Apex Molecular Limited

Apex Molecular Ltd, based in Alderley Edge, UK, is a small, active company founded 16 years ago. With 47 employees and £1,889,590 in assets, it operates from a real address and is managed by six directors, although no owners are officially listed. The company regularly imports and exports organic chemicals, with 80 months of import activity and 13 months of export activity recorded.

The company’s website highlights its role as a specialist chemistry service provider for the pharmaceutical, biotechnology, and applied chemistry sectors. It offers custom synthesis, contract synthesis, medicinal chemistry support, and development scale-up services, alongside the sale of specific compounds like linkers and controlled substances. Apex Molecular also partners with NovaData Solutions to provide computational chemistry services. The company’s facilities are described as state-of-the-art, enabling them to operate at scales from milliliters to low kilograms. Recent news includes the appointment of a medicinal chemistry consultant and participation in industry events.

Financially, Apex Molecular Ltd shows some concerning trends. Cash reserves decreased by 12% to £1,200,000, while bank borrowings increased by 94% to £5,400. Creditors decreased significantly by 46%, which is a positive sign, and current assets dropped by 6.8% to £1,900,000. The company’s small size—meeting two of three criteria for a small company—helps maintain agility, but the decline in cash and net assets is notable. Disposals of plant machinery decreased by 39% to £6,600. Although the company is exempt from an audit, the unaudited figures suggest a need for careful financial management. The company’s focus on high-value chemistry services, however, positions it well to potentially offset these challenges.

Registered in England/Wales under the registration number 06596885, with a registered address at SK10 4TG, England, Alderley Edge, Cheshire, Block 19 Alderley Park, Mereside.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.